Cargando…

Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis

PURPOSE: Although inhibitors of vascular endothelial growth factor and inhibitors of epidermal growth factor receptor (EGFRi) are commonly used for the treatment of metastatic colorectal cancer (mCRC), the optimal sequencing of these agents is currently unclear. METHODS: A national registry of targe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buchler, Tomas, Chloupkova, Renata, Poprach, Alexandr, Fiala, Ondrej, Kiss, Igor, Kopeckova, Katerina, Dusek, Ladislav, Veskrnova, Veronika, Slavicek, Lubomir, Kohoutek, Milan, Finek, Jindrich, Svoboda, Marek, Petruzelka, Lubos, Melichar, Bohuslav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314050/ https://www.ncbi.nlm.nih.gov/pubmed/30643461 http://dx.doi.org/10.2147/CMAR.S183093

Ejemplares similares

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry
por: Lakomy, Radek, et al.
Publicado: (2017)

Regorafenib for Metastatic Colorectal Cancer: An Analysis of a Registry-Based Cohort of 555 Patients
por: Novakova-Jiresova, Alena, et al.
Publicado: (2020)

Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients
por: Fiala, Ondrej, et al.
Publicado: (2020)

Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry
por: Slavicek, Lubomir, et al.
Publicado: (2014)

Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy—Data from the National Renis Registry
por: Poprach, Alexandr, et al.
Publicado: (2020)

Incidental Use of Beta-Blockers Is Associated with Outcome of Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Based Therapy: A Single-Institution Retrospective Analysis of 514 Patients
por: Fiala, Ondrej, et al.
Publicado: (2019)

Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis
por: Buchler, Tomas, et al.
Publicado: (2014)

The Association of Baseline Serum Tumour Markers with Outcome of Patients with Metastatic Colorectal Cancer Treated with Anti-EGFR Monoclonal Antibodies in the First Line
por: Fiala, Ondrej, et al.
Publicado: (2018)

Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry
por: Pavlík, Tomáš, et al.
Publicado: (2012)

Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view
por: Bencsikova, Beatrix, et al.
Publicado: (2015)

Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib
por: Fiala, Ondřej, et al.
Publicado: (2021)

Impact of Delaying the Addition of Anti-EGFR in First Line of RAS Wild-Type Metastatic Colorectal Cancer: A Propensity-Weighted Pooled Data Analysis
por: Palmieri, Lola-Jade, et al.
Publicado: (2022)

Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma
por: Fedorko, Michal, et al.
Publicado: (2017)

An Assessment of Novel Biomarkers in Bone Metastatic Disease Using Multiplex Measurement and Multivariate Analysis
por: Windrichova, Jindra, et al.
Publicado: (2018)

MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX
por: Kiss, I., et al.
Publicado: (2017)

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: results of the CECOG LaVie trial
por: Thallinger, Christiane, et al.
Publicado: (2016)

Colorectal cancer patients show decrease in cellular immunity and enhanced plasma level of transforming growth factor – beta and vascular endothelial growth factor (VEGF)
por: Zavadova, Eva, et al.
Publicado: (2013)

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy
por: Slaby, Ondrej, et al.
Publicado: (2010)

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy
por: Slaby, Ondrej, et al.
Publicado: (2010)

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
por: Redova, Martina, et al.
Publicado: (2012)

miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib
por: Merhautova, Jana, et al.
Publicado: (2015)

Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy
por: Holanek, Milos, et al.
Publicado: (2022)

Transgelin Contributes to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment
por: Bouchalova, Pavla, et al.
Publicado: (2021)

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses
por: Brodowicz, T, et al.
Publicado: (2014)

Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients
por: Iliev, Robert, et al.
Publicado: (2016)

The use of cisplatin in patients after kidney transplantation with chronic renal insufficiency: Is the benefit higher than potential risks in therapy of non-seminomatous germ cell tumors?
por: Pokrivcak, Tomas, et al.
Publicado: (2021)

Serum Adiponectin Relates to Shortened Overall Survival in Men with Squamous Cell Esophageal Cancer Treated with Preoperative Concurrent Chemoradiotherapy: A Pilot Study
por: Zemanová, Milada, et al.
Publicado: (2014)

Comprehensive characterization of complex glycosphingolipids in human pancreatic cancer tissues
por: Hořejší, Karel, et al.
Publicado: (2023)

Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer
por: Koleckova, Marketa, et al.
Publicado: (2021)

High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area
por: Pohlreich, Petr, et al.
Publicado: (2005)

Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence
por: Holanek, Milos, et al.
Publicado: (2021)

LncRNA PVT1 is increased in renal cell carcinoma and affects viability and migration in vitro
por: Bohosova, Julia, et al.
Publicado: (2022)

Risk factors of atherosclerosis during systemic therapy targeting vascular endothelial growth factor
por: ŠTUDENTOVÁ, HANA, et al.
Publicado: (2016)

Immune monitoring in patients with colorectal cancer stage II
por: Zavadova, Eva, et al.
Publicado: (2015)

Zebrabase: An Intuitive Tracking Solution for Aquatic Model Organisms
por: Oltova, Jana, et al.
Publicado: (2018)

Cyanobacteria Microcystis aeruginosa Contributes to the Severity of Fish Diseases: A Study on Spring Viraemia of Carp
por: Palikova, Miroslava, et al.
Publicado: (2021)

Long non-coding RNAs enable precise diagnosis and prediction of early relapse after nephrectomy in patients with renal cell carcinoma
por: Bohosova, Julia, et al.
Publicado: (2023)

Substantial Improvement of High Temperature Strength of New-Generation Nano-Oxide-Strengthened Alloys by Addition of Metallic Yttrium
por: Svoboda, Jiří, et al.
Publicado: (2022)

Combination Chemotherapy and Photodynamic Therapy with Fab′ Fragment Targeted HPMA Copolymer Conjugates in Human Ovarian Carcinoma Cells
por: Hongrapipat, Jarunee, et al.
Publicado: (2008)

Special Techniques of Adjuvant Breast Carcinoma Radiotherapy
por: Kolářová, Iveta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s70im0977ec888mhhf172f0dak